Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Aktienges ADR (OP: BAYRY )

13.94 -0.05 (-0.36%)
Streaming Delayed Price Updated: 3:59 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 364,195
Open 14.05
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 13.99
Today's Range 13.92 - 14.11
52wk Range 11.41 - 18.01
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Daily Stock Analysis: Bayer AG - May '23 Update
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as over the counter products. 
Via Talk Markets
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
Via Talk Markets

Performance

YTD
+7.07%
+7.07%
1 Month
-13.42%
-13.42%
3 Month
-8.05%
-8.05%
6 Month
+0.61%
+0.61%
1 Year
-22.12%
-22.12%

More News

Read More
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Via Benzinga
After That Big Merger, What Happened?
Via Talk Markets
InvestorNewsBreaks – ROTH MKM’s Agribusiness Investment Banking Group Serves as Sellside Advisor for Three M&A Transactions
Via Investor Brand Network
Topics Derivatives
Exposures Derivatives
Bayer: Aspirin To Crop Protection
Via Talk Markets
Russia Warns As Finland Joins NATO, Spotify Highlights Struggle With Live Audio, Anticompetitive Charges Against Activision Blizzard: Today's Top Stories
Via Benzinga
US Court Favors Bayer In Lawsuit Against Merck On Talc Liabilities
Via Benzinga
Evogene Offers An Excellent Risk/Reward Ratio
Via Talk Markets
Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
Via Benzinga
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
Via Benzinga
Bayer Snags Ex-Roche Exec Bill Anderson As New CEO; Shares Rocket
Via Investor's Business Daily
Investors Always Miss This Key Element
Via Talk Markets
Ring The Register; Plus, Where To Park Your Profits
Via Talk Markets
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
Via Benzinga
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories
Via Benzinga
Activist Investor Builds Stake In Bayer, Pushes Breakup
Via Benzinga
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down
Via Benzinga
Current Report: Bayer AG
Via Talk Markets
Ionis Regains Rights To Thrombosis Candidate From Bayer
Via Benzinga
Can Acquisitions and Partnerships Take Ginkgo Bioworks (DNA) Stock Higher?
Via InvestorPlace
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
Via InvestorPlace
Elon Musk Renews Twitter's Buyout Proposal, Apple Suppliers Working On Cutting China Reliance, E-Cigarette Maker Considers Bankruptcy: Top Stories Wednesday, Oct. 5
Via Benzinga
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
Via Benzinga
Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More...
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.